Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GENNEX LAB. vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GENNEX LAB. CIPLA GENNEX LAB./
CIPLA
 
P/E (TTM) x 35.0 32.2 108.4% View Chart
P/BV x 4.5 5.2 87.1% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 GENNEX LAB.   CIPLA
EQUITY SHARE DATA
    GENNEX LAB.
Mar-23
CIPLA
Mar-23
GENNEX LAB./
CIPLA
5-Yr Chart
Click to enlarge
High Rs91,185 0.8%   
Low Rs5852 0.6%   
Sales per share (Unadj.) Rs3.4281.9 1.2%  
Earnings per share (Unadj.) Rs0.335.1 0.8%  
Cash flow per share (Unadj.) Rs0.349.7 0.7%  
Dividends per share (Unadj.) Rs08.50 0.0%  
Avg Dividend yield %00.8 0.0%  
Book value per share (Unadj.) Rs4.5289.2 1.6%  
Shares outstanding (eoy) m176.64807.15 21.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.13.6 57.3%   
Avg P/E ratio x25.029.0 86.1%  
P/CF ratio (eoy) x21.020.5 102.5%  
Price / Book Value ratio x1.53.5 43.4%  
Dividend payout %024.2 0.0%   
Avg Mkt Cap Rs m1,229822,164 0.1%   
No. of employees `000NANA-   
Total wages/salary Rs m7938,301 0.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m593227,531 0.3%  
Other income Rs m405,121 0.8%   
Total revenues Rs m633232,653 0.3%   
Gross profit Rs m4748,079 0.1%  
Depreciation Rs m911,721 0.1%   
Interest Rs m141,095 1.2%   
Profit before tax Rs m6440,384 0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1512,029 0.1%   
Profit after tax Rs m4928,355 0.2%  
Gross profit margin %7.921.1 37.4%  
Effective tax rate %22.829.8 76.5%   
Net profit margin %8.312.5 66.5%  
BALANCE SHEET DATA
Current assets Rs m487168,051 0.3%   
Current liabilities Rs m29550,333 0.6%   
Net working cap to sales %32.351.7 62.4%  
Current ratio x1.63.3 49.4%  
Inventory Days Days473 5.5%  
Debtors Days Days57,912,5897 889,848,479.1%  
Net fixed assets Rs m835117,318 0.7%   
Share capital Rs m1801,614 11.2%   
"Free" reserves Rs m623231,845 0.3%   
Net worth Rs m804233,460 0.3%   
Long term debt Rs m1630-   
Total assets Rs m1,322290,067 0.5%  
Interest coverage x5.737.9 15.1%   
Debt to equity ratio x0.20-  
Sales to assets ratio x0.40.8 57.2%   
Return on assets %4.710.2 46.8%  
Return on equity %6.112.1 50.4%  
Return on capital %8.017.8 45.0%  
Exports to sales %42.122.6 186.1%   
Imports to sales %13.68.9 153.0%   
Exports (fob) Rs m25051,516 0.5%   
Imports (cif) Rs m8120,202 0.4%   
Fx inflow Rs m25064,282 0.4%   
Fx outflow Rs m8620,202 0.4%   
Net fx Rs m16444,080 0.4%   
CASH FLOW
From Operations Rs m23732,377 0.7%  
From Investments Rs m-383-23,885 1.6%  
From Financial Activity Rs m210-9,583 -2.2%  
Net Cashflow Rs m64-968 -6.6%  

Share Holding

Indian Promoters % 23.6 13.4 175.7%  
Foreign collaborators % 0.0 20.0 -  
Indian inst/Mut Fund % 0.0 50.0 -  
FIIs % 0.0 25.7 -  
ADR/GDR % 0.0 0.0 -  
Free float % 76.4 66.5 114.8%  
Shareholders   69,723 425,731 16.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GENNEX LAB. With:   DIVIS LABORATORIES    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on GENNEX LABORATORIES vs Cipla

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GENNEX LABORATORIES vs Cipla Share Price Performance

Period GENNEX LABORATORIES Cipla S&P BSE HEALTHCARE
1-Day 1.35% 1.94% 1.18%
1-Month -13.90% 1.25% -0.75%
1-Year 189.91% 68.02% 61.82%
3-Year CAGR 62.78% 22.53% 18.16%
5-Year CAGR 40.09% 23.24% 19.79%

* Compound Annual Growth Rate

Here are more details on the GENNEX LABORATORIES share price and the Cipla share price.

Moving on to shareholding structures...

The promoters of GENNEX LABORATORIES hold a 23.6% stake in the company. In case of Cipla the stake stands at 33.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GENNEX LABORATORIES and the shareholding pattern of Cipla.

Finally, a word on dividends...

In the most recent financial year, GENNEX LABORATORIES paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

Cipla paid Rs 8.5, and its dividend payout ratio stood at 24.2%.

You may visit here to review the dividend history of GENNEX LABORATORIES, and the dividend history of Cipla.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.